十一因子抑制剂:对末期病的潜在作用
Matthew Ades1, Camille Simard2, Thomas Vanassche3
1Division of General Internal Medicine, Department of Medicine, McGill University, Montreal, Canada.
Seminars in nephrology
|January 25, 2024
概括
新的XI因子抑制剂为末期脏疾病的血液透析患者提供更安全的抗凝剂,可能降低与当前疗法相关的出血风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 接受血液透析的末期病 (ESKD) 患者面临高血栓和出血风险.
- 目前的抗凝固药在这个脆弱人群中具有显著的出血风险.
- 在接受血液透析的ESKD患者中,急需更安全的抗血栓策略.
研究的目的:
- 审查关于XI因子 (FXI) 抑制剂的最新药理学数据.
- 要总结正在进行的临床试验 (第二阶段和第三阶段),涉及FXI抑制剂.
- 评估FXI抑制剂在血液透析期间在体外电路中抗凝的潜力.
主要方法:
- 关于FXI抑制剂的最近药理学研究的综述.
- 对2期和3期临床试验数据的分析.
- 讨论FXI抑制机制,包括反感性寡核酸,单克隆抗体和小分子.
- 检查FXI在体外电路激活中的作用.
主要成果:
- 抑制FXI是一种有前途的抗凝固方法,有可能降低出血风险.
- 各种针对FXI的疗法正在进行先进的临床开发.
- 由于电路诱导的凝血激活,FXI抑制对血液透析期间的抗凝血特别重要.
结论:
- FXI 抑制剂是治疗ESKD 血液透析患者抗血栓治疗的潜在进展.
- 这些药物可能为现有的抗凝剂提供更安全的替代品,特别是在高出血风险的个体中.
- 进一步的研究和临床试验至关重要,以确定FXI抑制剂在血液透析抗凝剂中的作用.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:11Renal Failure: Dose Adjustments
89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:17Factors Affecting Renal Clearance: Renal Impairment
95
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
01:22Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381